International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7899828
Original Article
A Study of Maternal Outcome in Complicated Eclampsia
 ,
 ,
 ,
 ,
Published
April 30, 2023
Abstract
Objective: To study sociodemographic parameters & various maternal complication in eclampsia patient. Method: A Prospective observational study was conducted in department of Obstetrics and Gynecology in Government medical college, Aurangabad. Result: It was observed that majority of the cases, 72% were between 20-25 years of age group , 46% were belonging to lower class, 54% cases were from rural residence, 64% cases were Unbooked hence 68.42% were referred without basic treatment. 82% cases had antepartum eclampsia, 14% had postpartum & 4% had intrapartum eclampsia encountered out of which 52% cases had undergone lower segment caesarean section. The most common complication encountered was Abruptio placenta followed by Pulmonary edema others include PRESS, HELLP syndrome with 6 maternal mortalities. Most cases required ICU management. 26% cases required Mechanical ventilation. Conclusion: Provision of quality antenatal health care services, timely reffral with treatment and delivery, intensive monitoring in the intrapartum and postpartum period have the potential to improve maternal and to prevent the occurrence of eclampsia as a whole.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
200 Views
332 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved